These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11200375

  • 1. Synergy of Bacteroides fragilis and Escherichia coli in the induction of KC gene expression in mouse peritoneal tissues.
    Kim JM, Kim YJ, Cho YJ.
    Scand J Infect Dis; 2000; 32(6):643-9. PubMed ID: 11200375
    [Abstract] [Full Text] [Related]

  • 2. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD, Kao J, Houston K.
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [Abstract] [Full Text] [Related]

  • 3. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD, Kao J.
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [Abstract] [Full Text] [Related]

  • 4. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL, Rotstein OD, Simmons RL.
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [Abstract] [Full Text] [Related]

  • 5. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
    Dunn DL, Barke RA, Ewald DC, Simmons RL.
    Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
    [Abstract] [Full Text] [Related]

  • 6. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
    Montravers P, Andremont A, Massias L, Carbon C.
    J Infect Dis; 1994 Apr; 169(4):821-30. PubMed ID: 8133097
    [Abstract] [Full Text] [Related]

  • 7. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I.
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I.
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [Abstract] [Full Text] [Related]

  • 9. Nosocomial bacteremia-induced increases in abscess formation correlate with in vitro upregulation of macrophage procoagulant activity.
    Sawyer RG, Pruett TL.
    Crit Care Med; 1995 Sep; 23(9):1554-9. PubMed ID: 7664558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Early events after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR, Namavar F, Schouten WF, MacLaren DM.
    J Med Microbiol; 1991 Jul; 35(1):18-22. PubMed ID: 2072375
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In-vitro activity of peritoneal cells from rats after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR, Namavar F, Schouten WF, Kostense PJ, Pellenkoft M, De Graaff J, MacClaren DM.
    J Med Microbiol; 1993 Jan; 38(1):13-8. PubMed ID: 8380297
    [Abstract] [Full Text] [Related]

  • 17. Effect of Escherichia coli lipopolysaccharide on Bacteroides fragilis abscess formation and mortality in mice.
    Tanaka Y, Jotwani R, Watanabe K, Tanaka K, Kato N, Ueno K.
    Microbiol Immunol; 1994 Jan; 38(2):97-102. PubMed ID: 8041306
    [Abstract] [Full Text] [Related]

  • 18. Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation.
    Sawyer RG, Adams RB, May AK, Rosenlof LK, Pruett TL.
    J Med Vet Mycol; 1995 Jan; 33(1):49-52. PubMed ID: 7650578
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy.
    Powers MR, Davies MH, Eubanks JP.
    Curr Eye Res; 2005 Apr; 30(4):299-307. PubMed ID: 16020260
    [Abstract] [Full Text] [Related]

  • 20. Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis.
    Otto BR, van Dooren SJ, Dozois CM, Luirink J, Oudega B.
    Infect Immun; 2002 Jan; 70(1):5-10. PubMed ID: 11748157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.